Drug therapy: Insulin analogues

[41] Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen [J]. DIABETES CARE, 2000, 23 (04) : 557 - 559

[42] Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin - absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects [J]. DIABETES CARE, 1999, 22 (09) : 1501 - 1506

[43] Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men -: Comparison with NPH insulin and the influence of different subcutaneous injection sites [J]. DIABETES CARE, 2000, 23 (06) : 813 - 819

[44] Pfutzner A, 1996, EXP CLIN ENDOCR DIAB, V104, P25

[45] Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cell - The role of protein kinase C and NAD(P)H-oxidase activation [J]. DIABETES, 2003, 52 (11) : 2795 - 2804

[46] A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes [J]. DIABETES CARE, 2000, 23 (11) : 1666 - 1671

[47] A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2001, 15 (06) : 295 - 300

[48] Optimal administration of lispro insulin in hyperglycemic type 1 diabetes [J]. DIABETES CARE, 1999, 22 (01) : 133 - 136

[49] Less hypoglycemia with insulin glargine in intensive insulin therapy for the 1 diabetes [J]. DIABETES CARE, 2000, 23 (05) : 639 - 643

[50] Use of insulin lispro in continuous subcutaneous insulin infusion treatment -: Results of a multicenter trial [J]. DIABETES CARE, 1999, 22 (05) : 784 - 788

[41] Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen [J]. DIABETES CARE, 2000, 23 (04) : 557 - 559

[42] Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin - absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects [J]. DIABETES CARE, 1999, 22 (09) : 1501 - 1506

[43] Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men -: Comparison with NPH insulin and the influence of different subcutaneous injection sites [J]. DIABETES CARE, 2000, 23 (06) : 813 - 819

[44] Pfutzner A, 1996, EXP CLIN ENDOCR DIAB, V104, P25

[45] Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cell - The role of protein kinase C and NAD(P)H-oxidase activation [J]. DIABETES, 2003, 52 (11) : 2795 - 2804

[46] A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes [J]. DIABETES CARE, 2000, 23 (11) : 1666 - 1671

[47] A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2001, 15 (06) : 295 - 300

[48] Optimal administration of lispro insulin in hyperglycemic type 1 diabetes [J]. DIABETES CARE, 1999, 22 (01) : 133 - 136

[49] Less hypoglycemia with insulin glargine in intensive insulin therapy for the 1 diabetes [J]. DIABETES CARE, 2000, 23 (05) : 639 - 643

[50] Use of insulin lispro in continuous subcutaneous insulin infusion treatment -: Results of a multicenter trial [J]. DIABETES CARE, 1999, 22 (05) : 784 - 788